ENSG00000147889


Homo sapiens

Features
Gene ID: ENSG00000147889
  
Biological name :CDKN2A
  
Synonyms : CDKN2A / cyclin dependent kinase inhibitor 2A / P42771 / Q8N726
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 9
Strand: -1
Band: p21.3
Gene start: 21967753
Gene end: 21995301
  
Corresponding Affymetrix probe sets: 207039_at (Human Genome U133 Plus 2.0 Array)   209644_x_at (Human Genome U133 Plus 2.0 Array)   211156_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000468510
Ensembl peptide - ENSP00000467390
Ensembl peptide - ENSP00000467857
Ensembl peptide - ENSP00000307101
Ensembl peptide - ENSP00000369496
Ensembl peptide - ENSP00000418915
Ensembl peptide - ENSP00000432664
Ensembl peptide - ENSP00000462950
Ensembl peptide - ENSP00000464202
Ensembl peptide - ENSP00000464952
Ensembl peptide - ENSP00000466887
NCBI entrez gene - 1029     See in Manteia.
OMIM - 600160
RefSeq - XM_011517679
RefSeq - NM_000077
RefSeq - NM_001195132
RefSeq - NM_058195
RefSeq - NM_058197
RefSeq - XM_005251343
RefSeq - XM_011517676
RefSeq Peptide - NP_478102
RefSeq Peptide - NP_000068
RefSeq Peptide - NP_478104
RefSeq Peptide - NP_001182061
swissprot - K7ES20
swissprot - K7PML8
swissprot - Q8N726
swissprot - P42771
swissprot - G3XAG3
swissprot - J3QRG6
swissprot - K7ENC6
Ensembl - ENSG00000147889
  
Related genetic diseases (OMIM): 155601 - {Melanoma, cutaneous malignant, 2}, 155601
  155755 - Melanoma and neural system tumor syndrome, 155755
  600160 - Orolaryngeal cancer, multiple,
  606719 - Pancreatic cancer/melanoma syndrome, 606719
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 cdkn2a/bENSDARG00000037262Danio rerio
 CDKN2BENSGALG00000026137Gallus gallus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
CDKN2B / P42772 / cyclin dependent kinase inhibitor 2BENSG0000014788363
CDKN2D / P55273 / cyclin dependent kinase inhibitor 2DENSG0000012935539
CDKN2C / P42773 / cyclin dependent kinase inhibitor 2CENSG0000012308033


Protein motifs (from Interpro)
Interpro ID Name
 IPR010868  Tumor suppressor ARF
 IPR020683  Ankyrin repeat-containing domain
 IPR036770  Ankyrin repeat-containing domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000082 G1/S transition of mitotic cell cycle IDA
 biological_processGO:0000209 protein polyubiquitination IDA
 biological_processGO:0001953 negative regulation of cell-matrix adhesion IMP
 biological_processGO:0006351 transcription, DNA-templated IEA
 biological_processGO:0006355 regulation of transcription, DNA-templated IEA
 biological_processGO:0006364 rRNA processing IEA
 biological_processGO:0006469 negative regulation of protein kinase activity IMP
 biological_processGO:0006915 apoptotic process IEA
 biological_processGO:0006919 activation of cysteine-type endopeptidase activity involved in apoptotic process IMP
 biological_processGO:0007049 cell cycle IEA
 biological_processGO:0007050 cell cycle arrest IMP
 biological_processGO:0007265 Ras protein signal transduction IEP
 biological_processGO:0008285 negative regulation of cell proliferation IMP
 biological_processGO:0008637 apoptotic mitochondrial changes IMP
 biological_processGO:0010389 regulation of G2/M transition of mitotic cell cycle IMP
 biological_processGO:0010628 positive regulation of gene expression IDA
 biological_processGO:0016310 phosphorylation IEA
 biological_processGO:0016925 protein sumoylation IEA
 biological_processGO:0030308 negative regulation of cell growth IDA
 biological_processGO:0030889 negative regulation of B cell proliferation ISS
 biological_processGO:0031647 regulation of protein stability ISS
 biological_processGO:0031648 protein destabilization IDA
 biological_processGO:0031658 negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle TAS
 biological_processGO:0032088 negative regulation of NF-kappaB transcription factor activity IDA
 biological_processGO:0033088 negative regulation of immature T cell proliferation in thymus ISS
 biological_processGO:0033235 positive regulation of protein sumoylation IMP
 biological_processGO:0034393 positive regulation of smooth muscle cell apoptotic process ISS
 biological_processGO:0035986 senescence-associated heterochromatin focus assembly IMP
 biological_processGO:0042326 negative regulation of phosphorylation IDA
 biological_processGO:0043065 positive regulation of apoptotic process IMP
 biological_processGO:0045736 negative regulation of cyclin-dependent protein serine/threonine kinase activity IDA
 biological_processGO:0045892 negative regulation of transcription, DNA-templated IMP
 biological_processGO:0045893 positive regulation of transcription, DNA-templated IDA
 biological_processGO:0045944 positive regulation of transcription by RNA polymerase II IDA
 biological_processGO:0048103 somatic stem cell division ISS
 biological_processGO:0050821 protein stabilization IDA
 biological_processGO:0051444 negative regulation of ubiquitin-protein transferase activity ISS
 biological_processGO:0070534 protein K63-linked ubiquitination IDA
 biological_processGO:0090398 cellular senescence IMP
 biological_processGO:0090399 replicative senescence IMP
 biological_processGO:1902510 regulation of apoptotic DNA fragmentation IMP
 biological_processGO:1904667 negative regulation of ubiquitin protein ligase activity IDA
 biological_processGO:1990000 amyloid fibril formation IMP
 biological_processGO:2000059 negative regulation of ubiquitin-dependent protein catabolic process IDA
 biological_processGO:2000111 positive regulation of macrophage apoptotic process ISS
 biological_processGO:2000435 negative regulation of protein neddylation IDA
 biological_processGO:2000774 positive regulation of cellular senescence IMP
 cellular_componentGO:0005634 nucleus IDA
 cellular_componentGO:0005654 nucleoplasm TAS
 cellular_componentGO:0005730 nucleolus IEA
 cellular_componentGO:0005737 cytoplasm IDA
 cellular_componentGO:0005739 mitochondrion IEA
 cellular_componentGO:0005829 cytosol TAS
 cellular_componentGO:0035985 senescence-associated heterochromatin focus IDA
 molecular_functionGO:0003677 DNA binding IEA
 molecular_functionGO:0003723 RNA binding HDA
 molecular_functionGO:0004861 cyclin-dependent protein serine/threonine kinase inhibitor activity IDA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0008134 transcription factor binding IPI
 molecular_functionGO:0016301 kinase activity IEA
 molecular_functionGO:0019789 SUMO transferase activity EXP
 molecular_functionGO:0019901 protein kinase binding IPI
 molecular_functionGO:0051059 NF-kappaB binding IDA
 molecular_functionGO:0055105 ubiquitin-protein transferase inhibitor activity ISS
 molecular_functionGO:0097718 disordered domain specific binding IPI
 molecular_functionGO:1990948 ubiquitin ligase inhibitor activity IDA


Pathways (from Reactome)
Pathway description
Oxidative Stress Induced Senescence
Senescence-Associated Secretory Phenotype (SASP)
Oncogene Induced Senescence
Cyclin D associated events in G1
SUMOylation of DNA damage response and repair proteins
SUMOylation of transcription factors
Regulation of TP53 Degradation
Stabilization of p53
Regulation of RUNX3 expression and activity


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000488 Retinopathy 
Show

 HP:0000819 Diabetes mellitus 
Show

 HP:0000952 Jaundice "Yellow pigmentation of the skin or sclera due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream." [HPO:curators]
Show

 HP:0000958 Dry skin 
Show

 HP:0001433 Hepatosplenomegaly 
Show

 HP:0001480 Freckling 
Show

 HP:0001595 Hair abnormality 
Show

 HP:0001738 Exocrine pancreatic insufficiency 
Show

 HP:0001824 Weight loss 
Show

 HP:0002017 Nausea and vomiting 
Show

 HP:0002027 Abdominal pain 
Show

 HP:0002039 Anorexia 
Show

 HP:0002071 Extrapyramidal signs 
Show

 HP:0002254 Intermittent diarrhea 
Show

 HP:0002448 Encephalopathy, progressive 
Show

 HP:0002665 Lymphoma "A cancer originating in lymphocytes and presenting as a solid tumor of lymhpoid cells." [HPO:curators]
Show

 HP:0002669 Osteogenic sarcoma 
Show

 HP:0002716 Lymphadenopathy 
Show

 HP:0002860 Squamous cell carcinoma 
Show

 HP:0002861 Malignant melanoma "A malignant skin tumor of originating from melanocytes, pigment cells normally present in the epidermis and sometimes in the dermis." [HPO:curators]
Show

 HP:0002894 Pancreatic cancer 
Show

 HP:0002896 Liver cancer 
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0003002 Breast cancer 
Show

 HP:0003003 Colon cancer 
Show

 HP:0003418 Back pain 
Show

 HP:0003764 Abnormal or excess nevi 
Show

 HP:0004375 Neoplasia of the nervous system 
Show

 HP:0004389 Intestinal pseudo-obstruction 
Show

 HP:0004396 Poor appetite 
Show

 HP:0005249 Functional intestinal obstruction 
Show

 HP:0006725 Pancreatic adenocarcinoma 
Show

 HP:0006753 Increased gastric cancer 
Show

 HP:0008069 Neoplasia of the skin 
Show

 HP:0009592 Astrocytoma "Astrocytoma is a neoplasm of the central nervous system derived from astrocytes." [HPO:curators]
Show

 HP:0012056 Cutaneous melanoma "The presence of a `melanoma` (MPATH:359) of the `skin` (FMA:7163)." [HPO:probinson]
Show

 HP:0012142 Pancreatic squamous cell carcinoma "A subtype of ductal pancreatic carcinoma that is thought to originate from squamous metaplasia of pancreatic ductal epithelium." [HPO:probinson, pmid:19079631]
Show

 HP:0012182 Oropharyngeal squamous cell carcinoma "A squamous cell carcinoma that originates in the oropharnyx." [HPO:probinson]
Show

 HP:0012334 Extrahepatic cholestasis "Impairment of bile flow due to obstruction in large bile ducts outside the liver." [HPO:probinson]
Show

 HP:0012432 Chronic fatigue "Subjective feeling of tiredness characterized by a lack of energy and motivation that persists for six months or longer." [ORCID:0000-0001-5208-3432]
Show

 HP:0025318 Ovarian carcinoma "A malignant neoplasm originating from the surface ovarian epithelium." []
Show

 HP:0100013 Neoplasia of the breast 
Show

 HP:0100242 Sarcoma "The presence of a `sarcoma` (MPATH:551)." [HPO:sdoelken]
Show

 HP:0100273 Neoplasia of the colon 
Show

 HP:0100592 Peritoneal abscess "The presence of an `abscess` (MPATH:608) of the `peritoneum` (FMA:9584)." [HPO:probinson]
Show

 HP:0100641 Cortical adrenal neoplasia 
Show

 HP:0100763 Abnormality of the lymphatic system 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000105810 CDK6 / Q00534 / cyclin dependent kinase 6  / reaction / complex
 ENSG00000198625 MDM4 / O15151 / MDM4, p53 regulator  / complex / reaction
 ENSG00000141510 TP53 / P04637 / tumor protein p53  / complex / reaction
 ENSG00000135679 MDM2 / Q00987 / MDM2 proto-oncogene  / complex / reaction
 ENSG00000135446 CDK4 / P11802 / cyclin dependent kinase 4  / reaction / complex






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr